What are the cervical screening programs? Medical experts will tell you

First of all, I would like to remind all women that it is best to have regular cervical examinations to rule out related diseases and is good for your health. Cervical examination requires multiple examination items, such as colposcopy and cervical biopsy, etc.

1. Cervical cancer screening costs and item details:

1. Cervical exfoliated cell examination (cervical smear): Guangzhou reference price: 50 yuan

2. TCT (liquid-based thin layer cytology test): Guangzhou reference price: 200 yuan

3. Colposcopy: Guangzhou reference price: 55 yuan, electronic mirror 105 yuan

4. Human papillomavirus (HPV) gene high-risk test: Guangzhou reference price: 350 yuan

5. Cervical biopsy: Guangzhou reference price: 65 yuan (cervical biopsy)

6. Cervical cone resection examination: Guangzhou examination reference price: 1,000 yuan (cervical cone resection)

2. Gynecological examination: First check for cervical erosion. If so, TCT examination can be done. Focus on checking the size, shape, texture, thickness of the cervical canal, and whether there is contact bleeding. Secondly, check the condition of the vulva, vagina, uterus, and paracervical tissues (ovaries, fallopian tubes, pelvic lymph nodes).

3. HPV test: This test is mainly to check whether the cervix is ​​infected with human papillomavirus. Scientists have now proven that the HPV virus transmitted through sexual intercourse is the main cause of cervical cancer. High-risk HPV testing to capture early cervical cancer is a rapid and effective detection method that has just been invented and developed by the medical community in recent years. It can detect all 13 high-risk HPV viruses that cause cervical cancer at one time, bringing the cervical cancer detection rate to over 99%. This method is simple, easy, non-invasive and painless. Regular high-risk HPV virus testing can detect HPV virus infection early and provide early treatment.

4. The cost of cervical cancer screening is actually not high, but the focus of the screening program should be on those high-risk women rather than on the number of screenings. For high-risk women, the screening interval should be shorter, preferably once a year. Moreover, HPV is the main cause of CIN and cervical cancer. HPV-DNA testing can predict the risk of lesion deterioration or postoperative recurrence, and effectively guide postoperative follow-up.